Fuzziez Cat’s Claw: what the label says — and doesn’t

What the brand itself says

Unlike most of the cat’s-claw tablet wave, Fuzziez has a real marketing footprint, so there are claims to examine: “botanical relaxation tablets,” 100mg of cat’s-claw extract per tablet, six flavors, kratom-free, THC-free, 21+, legal in all 50 states — and a proprietary blend featuring “an indole alkaloid from the Cat’s Claw plant” that isn’t named further. Those are Fuzziez’s statements, not ours.

Set next to the published science, one tension stands out: cat’s claw’s named alkaloids show no measurable opioid-receptor binding in published data. A tablet promising a relaxing experience from an unnamed alkaloid of that same plant is either a mild botanical wearing big marketing — or it’s built on an isolated compound the label doesn’t identify. We don’t know which, and that’s the point: without a published third-party panel naming the alkaloid and the dose, nobody outside the factory knows.

The category context is public record: Utah Poison Control’s July 2026 alert on adulterated cat’s-claw and kava products, and the Missouri Attorney General’s investigation into manufacturers. Category-level warnings — we’ve seen no lab data on Fuzziez specifically, in either direction.

The same question as every tablet in this wave

“Can I see the third-party panel for this batch?” A document answers it; nothing else does. Our kratom and mitragynine lines are third-party tested. The cat’s claw we carry isn’t, and we won’t pretend otherwise. For the wider picture on this category, start with cat’s claw vs kratom or the Dopium breakdown; coming from 7-OH, the switchboard maps every format to a tested landing spot — Hydroxie Mitragynine-A and Dozo MG-X.